I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Doit-on continuer à indiquer le Glucantime®en première inte..:
Benmously, R.
;
Ben Hamida, M.
;
Hammami, H.
..
Annales de Dermatologie et de Vénéréologie. 138 (2011) 12 - p. A250 , 2011
Link:
https://doi.org/10.1016/j.annder.2011.10.301
RT Journal T1 <Title>Doit-on continuer à indiquer le Glucantime®en première intention pour le traitement des leishmanioses cutanées en Tunisie ?</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.annder.2011.10.301&Exemplar=1&LAN=DE A1 Benmously, R. A1 Ben Hamida, M. A1 Hammami, H. A1 Fenniche, S. A1 Mokhtar, I. PB Elsevier BV YR 2011 SN 0151-9638 JF Annales de Dermatologie et de Vénéréologie VO 138 IS 12 SP A250 LK http://dx.doi.org/https://doi.org/10.1016/j.annder.2011.10.301 DO https://doi.org/10.1016/j.annder.2011.10.301 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
